1
Return

Once-daily dolutegravir–based antiretroviral therapy amongst adults with advanced HIV disease receiving 1-month of daily rifapentine and isoniazid for TB preventive therapy and fluconazole for treatment of cryptococcal meningitis: results of a pharmacokinetic study

delete2026-07-08
delete0
delete
OA
AI
J
Jayne Ellis *
G
Gila Hale
A
Allan Buzibye
D
Denis Omali
S
Sandra Naluyima
N
Nathan Ntenkaire
L
Laura J Nsangi
J
Jane Frances Ndyetukira
A
Alisat Sadiq
C
Cynthia Ahimbisibwe
S
Shifah Nabbaale
A
Asmus Tukundane
W
Wilber Bakka
J
Jane Gakuru
A
Aida N Kawuma
D
David A J Moore
D
David B Meya
D
David R Boulware
C
Catriona Waitt
J
Joseph N Jarvis
M
Melanie R Nicol
DOI：10.1093/ofid/ofag415delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
One month of daily isoniazid and rifapentine (1HP) is an efficacious, well-tolerated, and safe TB preventive therapy regimen. 1HP implementation has been slow due to concern about drug-drug interactions with rifapentine.

Journal

Open Forum Infectious Diseases cover
Open Forum Infectious Diseases
IF:
3.8
Papers:
6.3K
Citations:
1.4W

Organization

M
makerere university
Scholars:
8.7K
Papers: 5.2K
Citations: 8
L
London School of Hygiene and Tropical Medicine
Scholars:
1.6K
Papers: 1.0K
Citations: 1.9W
U
university of minnesota
Scholars:
3.2K
Papers: 1.5K
Citations: 0
Cited Papers

Cited Papers

Citing Papers

Citing Papers